昭衍新药
(603127)
| 流通市值：265.44亿 | | | 总市值：315.55亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-01-09 | 1272.74万 | 1.38% | 13.81万 | 0.02% | -4251.02万 | -4.62% | 2964.48万 | 3.22% |
| 2026-01-08 | 961.53万 | 0.84% | 7909.17万 | 6.87% | 4650.10万 | 4.04% | -13520.80万 | -11.74% |
| 2026-01-07 | 3313.20万 | 2.21% | 14809.48万 | 9.89% | 81.38万 | 0.05% | -18204.06万 | -12.16% |
| 2026-01-06 | -4893.84万 | -3.74% | -1566.82万 | -1.20% | -4811.51万 | -3.68% | 11272.17万 | 8.61% |
| 2026-01-05 | 24068.82万 | 23.30% | -582.92万 | -0.56% | -9686.88万 | -9.38% | -13799.02万 | -13.36% |
| 2025-12-31 | -2418.69万 | -4.10% | -3395.56万 | -5.75% | 1665.91万 | 2.82% | 4148.35万 | 7.03% |
| 2025-12-30 | -8492.02万 | -7.40% | -10184.18万 | -8.88% | -1863.86万 | -1.63% | 20540.05万 | 17.91% |
| 2025-12-29 | -1874.52万 | -2.74% | -941.96万 | -1.38% | 1850.38万 | 2.70% | 966.10万 | 1.41% |
| 2025-12-26 | -3911.53万 | -5.92% | -1538.43万 | -2.33% | 3309.79万 | 5.01% | 2140.18万 | 3.24% |
| 2025-12-25 | 5442.70万 | 5.80% | 10968.67万 | 11.68% | -2896.75万 | -3.09% | -13514.63万 | -14.39% |